Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 70

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies

Laffel, Lori·2016·Diabetes Technology & Therapeutics

Abstract

Objective: This study was designed to evaluate accuracy, performance, and safety of the Dexcom (San Diego, CA) G4 ® Platinum continuous glucose monitoring (CGM) system (G4P) compared with the Dexcom G4 Platinum with Software 505 algorithm (SW505) when used as adjunctive management to blood glucose (BG) monitoring over a 7-day period in youth, 2–17 years of age, with diabetes. Research Design and Methods: Youth wore either one or two sensors placed on the abdomen or upper buttocks for 7 days, calibrating the device twice daily with a uniform BG meter. Participants had one in-clinic session on Day 1, 4, or 7, during which fingerstick BG measurements (self-monitoring of blood glucose [SMBG]) were obtained every 30 ± 5 min for comparison with CGM, and in youth 6–17 years of age, reference YSI glucose measurements were obtained from arterialized venous blood collected every 15 ± 5 min for comparison with CGM. The sensor was removed by the participant/family after 7 days. Results: In comparison of 2,922 temporally paired points of CGM with the reference YSI measurement for G4P and 2,262 paired points for SW505, the mean absolute relative difference (MARD) was 17% for G4P versus 10% for SW505 ( P < 0.0001). In comparison of 16,318 temporally paired points of CGM with SMBG for G4P and 4,264 paired points for SW505, MARD was 15% for G4P versus 13% for SW505 ( P < 0.0001). Similarly, error grid analyses indicated superior performance with SW505 compared with G4P in comparison of CGM with YSI and CGM with SMBG results, with greater percentages of SW505 results falling within error grid Zone A or the combined Zones A plus B. There were no serious adverse events or device-related serious adverse events for either the G4P or the SW505, and there was no sensor breakoff. Conclusions: The updated algorithm offers substantial improvements in accuracy and performance in pediatric patients with diabetes. Use of CGM with improved performance has potential to increase glucose time in range and improve glycemic outcomes for youth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2015.0380

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 26

  1. 10.1016/j.jpeds.2009.05.025 · DOI · Paper page
  2. 10.1210/jc.2012-1561 · DOI · Paper page
  3. 10.2337/dc12-1959 · DOI · Paper page
  4. 10.1016/j.jpeds.2007.03.047 · DOI
  5. 10.2337/dc07-1995 · DOI
  6. 10.1111/j.1399-5448.2008.00476.x · DOI
  7. 10.1089/dia.2010.0021 · DOI
  8. 10.1111/j.1399-5448.2011.00837.x · DOI · Paper page
  9. 10.2337/dc09-0889 · DOI · Paper page
  10. 10.1111/j.1464-5491.2011.03368.x · DOI
  11. 10.1177/193229681100500407 · DOI
  12. 10.2337/dc10-1054 · DOI
  13. 10.1177/1932296814559302 · DOI
  14. 10.1177/1932296814532203 · DOI
  15. 10.1089/dia.2013.0077 · DOI
  16. 10.1159/000411605 · doi:10.1159/000411605
  17. 10.2337/diacare.10.5.622 · DOI · Paper page
  18. 10.2337/diacare.23.8.1143 · DOI · Paper page
  19. 10.1056/NEJMoa1314474 · DOI · Paper page
  20. 10.2337/dc13-2076 · DOI · Paper page
  21. 10.2337/diacare.28.8.1929 · DOI
  22. 10.1111/j.1399-543X.2006.00142.x · DOI
  23. 10.1089/dia.2011.0201 · DOI
  24. 10.2337/dc12-2021 · DOI
  25. 10.1111/j.1399-5448.2011.00793.x · DOI
  26. 10.1177/193229681300700211 · DOI

Cited by

See all 70

Metadata

Authors
Laffel, L.
Affiliations
Joslin Diabetes Center
Venue
Diabetes Technology & Therapeutics
Published
2016-02
Volume
18
Issue
2_suppl
ISSN
  • 1520-9156
  • 1557-8593
Cited by
70
References
14
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. https://app.cochat.ai/papers/10.1089/dia.2015.0380
The paper
Laffel, L. (2016). Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2015.0380

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.